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A Nafion(5 pre-coats/2 dip-coats)-modified Pt sensor developed for real-time neurochemical
monitoring has now been characterised in vitro for the sensitive and selective detection of nitric oxide
(NO). A potentiodynamic profile at bare Pt established +0.9 V (vs. SCE) to be the most appropriate
applied potential for NO oxidation. The latter was confirmed using oxyhaemoglobin and N2, both of
which reduced the NO signal to baseline levels. Results indicated enhanced NO sensitivity at the
Nafion(5/2) sensor (1.67  0.08 nA mM1) compared to bare Pt (1.08  0.20 nA mM1) and negligible
interference from a wide range of endogenous electroactive interferents such as ascorbic acid,
dopamine and its metabolites, NO2
 and H2O2. The response time of 33.7 2.7 s was found to improve
(19.0  3.4 s) when the number of Nafion layers was reduced to 2/1 and an insulating outer layer
of poly(o-phenylenediamine) added. When tested under physiological conditions of 37 C the response
time of the Nafion(5/2) sensor improved to 14.00  2.52 s. In addition, the NO response was not
affected by physiological concentrations of O2 despite the high reactivity of the two species for each
other. The limit of detection (LOD) was estimated to be 5 nM while stability tests in lipid
(phosphatidylethanolamine; PEA) and protein (bovine serum albumin; BSA) solutions (10%) found an
initial ca. 38% drop in sensitivity in the first 24 h which remained constant thereafter. Preliminary
in vivo experiments involving systemic administration of NO and L-arginine produced increases in the
signals recorded at the Nafion(5/2) sensor implanted in the striatum of freely-moving rats, thus
supporting reliable in vivo recording of NO.
Introduction
Nitric oxide (NO) is an intracellular signalling molecule that
performs a variety of roles throughout the body. It regulates
vascular tone, acts as a neuronal signal in the gastrointestinal
tract and central nervous system, and contributes to the
pathology of several diseases including hypertension, Parkin-
son’s disease and Alzheimer’s disease.
The same properties that allow NO to carry out its diverse
physiological and pathological processes also present problems
concerning its qualitative and quantitative analysis in biological
systems. Like all free radicals, NO is extremely reactive and has
a high affinity for interaction with ferrous haemoproteins
such as soluble guanylate cyclase1 and haemoglobin,2,3 while
also reacting readily with O2, peroxides and the superoxide
anion (O2
).4
The majority of NO monitoring methods that are currently
available measure NO indirectly and are hindered by significant
drawbacks. The most commonly used methods found in the
literature are electron paramagnetic resonance (EPR),5,6 chem-
iluminescence,7,8 UV-visible spectroscopy,9–11 fluorescence12,13
and electrochemistry.14–18 Of these techniques, electrochemical
methods are most advantageous because of their speed and
sensitivity,19–21 which are particularly important for NO as it is
present at nanomolar concentrations and has a half-life of 2–6 s
in vivo.22 Thus, the possibility of using microelectrochemical
sensors for real-time NO measurement has recently gained
considerable interest.14,23–27
For a number of years we have been using Long-term In Vivo
Electrochemistry (LIVE), i.e. the detection of substances using
amperometric electrodes (sensors/biosensors) and electro-
chemical techniques in vivo, to study neurochemical phenomena
in the living brain.28,29 We have recently become interested in
developing a new sensor for monitoring brain extracellular levels
of NO. However, the mammalian brain is a hostile environment
for implanted sensors as it contains electrode poisons (e.g. lipids
and proteins) and a large number of possible interfering species
present at relatively high concentrations (e.g. ascorbic acid (AA),
uric acid (UA), and the catecholamines and their metabolites).
As a first step in our development process various Nafion
coating procedures on Pt were examined in order to design
a simple and reproducible coating method to maximise permse-
lective characteristics.30 Application of Nafion (5% commercial
solution) using a thermally annealing procedure involving
5 pre-coats, and 2 subsequent dip-bake layers resulted in elimi-
nation of interferent signals from AA (the principal endogenous
electroactive interferent present in the brain), UA and dopamine.
We have also recently established and characterised a consistent
and reproducible method of the preparation of NO stock
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solutions in order to enable accurate calibration of our new
NO sensor both prior to, and after, implantation.31
In this paper we present results of a detailed in vitro charac-
terisation of the Nafion(5/2)-modified microelectrochemical
Pt sensor with respect to brain extracellular NO monitoring. We
also present preliminary in vivo data from experiments designed
to characterise the sensor’s performance in its target biological
environment.
Experimental
Reagents and solutions
The Nafion (1100 EW, 5 wt% solution in a mixture of lower
aliphatic alcohols and H2O) was obtained from Aldrich Chem-
ical Co., Dorset, UK. L-Ascorbic acid (AA; A.C.S. reagent),
uric acid (UA; sodium salt), dopamine (DA; hydrochloride),
3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid
(HVA), 5-hydroxytryptamine (5-HT; hydrochloride), 5-hydroxy-
indole-3-acetic acid (5-HIAA), glutathione (oxidised disodium
salt), o-phenylenediamine (99+%), haemoglobin (bovine lyoph-
ilized powder), L-a-phosphatidylethanolamine (PEA; Type II-S,
commercial grade), L-arginine and H2O2 (A.C.S. reagent, 30.4%)
were obtained from Sigma-Aldrich Ireland Ltd. Bovine Serum
Albumin (BSA; Fraction V) was obtained from Fluka Chem-
icals, Dorset, UK. The NaCl (SigmaUltra), NaH2PO4 (Sigma,
A.C.S. reagent) and NaOH (SigmaUltra) were used as supplied.
NO stock solutions were prepared fresh using neutral Griess
reagent following a previously described procedure.31 Stock
standard solutions of all other compounds were prepared at the
beginning of each experiment to avoid problems associated with
gradual decomposition. Solutions of oxyhaemoglobin (oxyHb;
0.1 mM) were prepared by dissolving 0.04 g of haemoglobin in
25 mL distilled deionised water and purging with O2 gas. 10%
solutions of BSA and PEA were prepared in distilled deionised
water and chloroform respectively. In vitro experiments were
carried out in phosphate buffer saline (PBS) solution, pH 7.4
(0.15 M NaCl, 0.04 M NaH2PO4 and 0.04 M NaOH), which was
deaerated with O2-free N2 for 20 minutes prior to commencing
electrochemical measurements. All solutions were prepared using
deoxygenated doubly distilled deionised water unless otherwise
stated, and stored at 4 C between injections. In in vivo experi-
ments, solutions of normal saline (1.0 mL/kg, 0.9% NaCl),
NO (500–1200 mM), and L-arginine (300 mg/kg) were adminis-
tered by intraperitoneal (i.p.) injection.
Working electrode preparation
Pt disk electrodes were made from Teflon-insulated platinum/
iridium (Pt/Ir 90%/10%) wire (125 mm bare diameter, 175 mm
coated diameter (5T), Advent Research Materials, Suffolk, UK).
The electrodes were approximately 5 cm in length and were
prepared by carefully cutting 5 mm of the Teflon insulation from
one end of the wire. A gold electrical contact (Semat Technical,
Herts, UK) was soldered to this end of the wire to enable
connection with the instrumentation. The other end of the wire
acted as the active (disk) surface of the electrode.
Nafion modification of the active surface was performed
following a previously reported pre-cast procedure. Briefly, pre-
casting involves placing an under layer of concentrated Nafion
onto the electrode surface. This is achieved by placing a droplet
of Nafion onto a watch glass. This droplet is then allowed to air
dry at room temperature for 5 minutes. After drying, further
individual drops (5) are placed on top of the initial droplet using
the same procedures. This produces a localised concentrated
layer of Nafion on the watch glass. A further drop of Nafion is
then placed on top of this concentrated pre-coated Nafion layer.
The active surface of the electrode is dipped into this concen-
trated layer and then immediately removed and allowed to air
dry at room temperature for 2 minutes. The final fresh Nafion
droplet is required to adhere the concentrated Nafion layer to
the electrode. This electrode is then placed into an oven and
baked for 5 minutes at 210 C. After baking, the electrode is then
further coated with a second Nafion layer by repeating the
dip-bake procedure, resulting in what we term a 5 pre-coat and
2 dip-coat (Nafion(5/2)) sensor.
For some experiments the number of coatings was reduced to
produce a Nafion(2/1) sensor which was then coated with an
outer layer of poly(o-phenylenediamine) (Nafion(2/1)-PPD)
following a previously described electropolymerisation
procedure.32–34 When not in use all electrodes where stored dry at
room temperature.
Characterisation of Nafion-modified Pt electrodes
All calibrations were performed in a standard three-electrode
glass electrochemical cell which was constructed in-house.
A saturated calomel electrode (SCE) was used as the reference
electrode and a large Pt wire served as the auxiliary electrode. To
facilitate mixing, solutions were bubbled with N2 for ca. 5 s
following the addition of each aliquot unless otherwise stated.
The current was then measured under quiescent conditions with
an N2 atmosphere maintained over the solution.
Concentrations of NO injected into the electrochemical cell
were not mixed using N2 gas due to the possibility of being
displaced from the PBS electrolyte. Mixing was facilitated
instead by use of a magnetic stirrer for approximately 5 s. For
NO sensors calibrated in PBS containing 50 mM O2, a second
pre-calibrated O2 electrode (bare Pt) was used to continuously
monitor the solution concentration of O2 by measuring the
O2 reduction current at550 mV vs. SCE. The measured current
was maintained at that for 50 mM O2 by accurately controlling
a gaseous mixture of air (RENA 102 air pump) and N2 (British
Oxygen Co. (BOC)) entering the electrochemical cell. Once the
reduction current was stable and representative of 50 mM O2
the NO calibration was commenced. All calibrations were
performed at room temperature unless otherwise stated.
Instrumentation and software
Scanning electron microscopy was performed on a JEOL
JSM-5410 SEM (EDAX, UK) operating with a 15 kV acceler-
ating voltage. Constant potential amperometry (CPA) was
performed in all electrochemical experiments using a low-noise
potentiostat (Biostat II, Electrochemical and Medical Systems,
Newbury, UK). Data acquisition was carried out with a Gateway
GP6-350 computer, a Powerlab/400 interface system (ADIn-
struments Ltd., Oxford, UK) and Chart for Windows (v 4.0.1)
software (ADInstruments Ltd.).
This journal is ª The Royal Society of Chemistry 2009 Analyst, 2009, 134, 2012–2020 | 2013
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All analysis was performed using Microsoft Excel and Prism
(GraphPad Software Inc., CA, USA). The significance of
differences observed was estimated using the Student’s t-test for
paired or unpaired observations where appropriate. Two-tailed
levels of significance were used and P < 0.05 was considered to be
significant. All data are presented as mean  S.E.M.
Surgical procedures
Male Wistar rats weighing 200–300 g were anesthetised,
following published guidelines,35 with a mixture of Hypnorm
(fentanyl citrate/fluanisone, Janssen Pharmaceuticals Ltd.,
Oxford, UK), Hypnovel (midazolam, Roche Products Ltd.,
Herts, UK), and sterile water, mixed 1 : 1 : 2 and injected i.p. at
a volume of 3.3 mL/kg, as described previously.36,37 Once surgical
anaesthesia was established, animals were placed in a stereotaxic
frame and the electrodes implanted following a previously
described procedure.36 Pt/Nafion(5/2)-modified electrodes, for
monitoring NO, were implanted bilaterally in the right and left
striatum: coordinates with the skull levelled between bregma and
lambda, were: A/P + 1.0 from bregma, M/L  2.5, and D/V5.0
from dura.38 A reference electrode (8T Ag wire, 200 mm bare
diameter; Advent Research Materials) was placed in the cortex
and an auxiliary electrode (8T Ag wire) attached to one of the
support screws (see below). The reference potential provided by
the Ag wire in brain tissue is very similar to that of the SCE.39
The electrodes were fixed to the skull with dental screws and
dental acrylate (Associated Dental Products Ltd., Swindon,
UK). Surgery typically lasted 40 min and anesthesia was reversed
by an i.p. injection of naloxone (0.1 mg/kg, Sigma Chemical Co.).
Post-operative analgesia was provided in the form of a single
injection (0.1 mg/kg, subcutaneous ) of Vetergesic (Buprenor-
phine hydrochloride, Reckitt and Colman Pharmaceuticals,
Hull, UK) given immediately following the surgery. Animals
were allowed to recuperate for 24 h after surgery and were
assessed for good health according to published guidelines40
immediately after recovery from anesthesia and at the beginning
of each day. This work was carried out under license in accor-
dance with the European Communities Regulations 2002
(Irish Statutory Instrument 566/2002 – Amendment of Cruelty to
Animals Act 1876).
Experimental conditions in vivo
Rats were housed in large plastic bowls (diameter ca. 50 cm), in
a windowless room under a 12 h light, 12 h dark cycle, lights
coming on at 8 am, with free access to water. Food was available
ad libitum. All experiments were carried out with the animal in its
home bowl. Implanted electrodes were connected to the poten-
tiostat after the 24 h recuperation period, through a six-pin
Teflon socket and a flexible screened six core cable which was
mounted through a swivel above the rat’s head (Semat Technical
Ltd.). This arrangement allowed free movement of the animal
which remained continuously connected to the instrumentation.
After application of the applied potential each animal was given
a further 24 h before experiments were begun in order to ensure
that the background currents for the electrodes were completely
stabilised. A low-pass digital filter (50 Hz cut-off) was used to
eliminate mains AC noise and all data were recorded at 10 Hz.
Results and discussion
Potentiodynamic profile of NO
Previous reports indicate that NO can be oxidised or reduced at
bare Pt disk electrodes.41–44 However, NO reduction requires an
applied potential of ca. 900 mV17 and is thus not an ideal
detection method at electrodes designed for in vivo applications.
This is primarily because other low molecular weight highly
permeable species, such as tissue O2, can be reduced at similar
reduction potentials (e.g. 550 mV vs. SCE).21,45 Oxidation of
NO is thus the preferred method of detection as the faradaic
NO signal is not contaminated by O2 at positive potentials
23 even
though the gaseous O2 molecule can permeate most interferent-
rejecting membranes. NO oxidation has previously been
reported to occur between +600 mV and +900 mV at bare
Pt electrodes.23,46–48
In order to determine the most appropriate oxidation potential
for NO at our Pt disk microelectrodes we carried out a potentio-
dynamic profile for NO from 0 to +900 mV. A complete calibra-
tion (n ¼ 4) for NO was performed over a relevant physiological
concentration range (0–1 mM, see inset Fig. 1) at 0, 200, 400, 600,
700, 800 and 900 mV at bare Pt. A plot of the slope vs. applied
potential is shown in Fig. 1. NO oxidation commenced at ca.
400 mV and increased with increasing applied potential reaching
a plateau after ca. 800 mV: 0.13  0.02 nA mM1 (400 mV);
0.49  0.06 nA mM1 (600 mV); 1.22  0.13 nA mM1 (700 mV);
2.04  0.05 nA mM1 (800 mV); 2.32  0.29 nA mM1 (900 mV).
All calibrations were linear (mean r2 ¼ 0.98  0.01, n ¼ 5) and
although there was no significant difference in the sensitivities
observed at +800 and +900 mV (P ¼ 0.91) we decided, because
of the short half-life of NO and that fact that most interferents
would oxidise below +800 mV, that it would be preferable to
operate the sensor at the higher applied potential given the likely
advantage of a faster response time.21
Verification of NO signal
NO is a very difficult gaseous analyte to work with in an
experimental setup, primarily because of its high reactivity with
O2.
48–50 NO can react with O2 to give the oxidation product
NO2
 and then undergo even further oxidation to produce
NO3
.46,51 We thus decided to confirm the authenticity of the
Fig. 1 The current–potential profile for 1 mM NO at bare Pt disk elec-
trodes at 0, +200, +400, +600, +700, +800 and +900 mV vs. SCE (n ¼ 4).
Inset: Typical steady state currents obtained for a 0–1 mM NO calibration
at +900 mV vs. SCE; arrows indicate injections of 0.2, 0.4, 0.6, 0.8 and
1 mM NO.
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in vitro NO signal recorded in calibrations at our Pt microelec-
trodes. This was achieved using oxyhaemoglobin (OxyHb) and
N2. OxyHb is an efficient NO scavenger
21,27,46 – NO reacts
rapidly with oxyHb to from nitrate and methaemoglobin,2 while
N2 displacement of NO in solution has previously been reported
by other research groups.46,47
Addition of N2 at the end of a full NO calibration resulted in
a rapid decrease in the 1 mM signal to background levels
(see Fig. 2A) while injection of 6 mM OxyHb to a solution con-
taining 200 nM NO had a similar effect with the faradaic current
also rapidly decreasing to background levels (see Fig. 2B). These
results confirm that our analyte signal is due to NO oxidation.
Interference studies
As already outlined, the mammalian brain is a hostile environ-
ment for implanted sensors as it contains electrode poisons
(e.g. lipids and proteins) and a large number of possible inter-
fering species present at relatively high concentrations (e.g.
ascorbic acid (AA), uric acid (UA), and the catecholamines
(e.g. dopamine, DA) and their metabolites). The success or
failure of a sensor designed for in vivo neurochemical applica-
tions is generally decided by its ability to eliminate interferent
signals while maintaining sufficient sensitivity for the target
analyte. One of the most common methods of achieving this
desired characteristic is the use of permselective membranes52–58
which are generally dip-coated46,59–62 or electropolymerised onto
the electrode surface.14,32,54,55,58,63–68
However, because NO is a gaseous molecule present a low
concentrations in vivo (tens of nanomoles to low micromoles)49
conventional membranes and application procedures rarely
produce the desired sensitivity and selectivity. One polymer with
the potential to successfully address this is Nafion. Electrodes
modified with Nafion have traditionally been used for the
detection of species such as DA67,69,70 due to their ability to pre-
concentrate the cationic catecholamine and minimise interfer-
ence from the various endogenous anionic species (e.g. AA)
present in the extracellular fluid (ECF).16,26,27,71–73 Such permse-
lective Nafion coatings have been applied to electrode surfaces
using a variety of techniques including dip-coating,74 spin-
coating75 electrostatic spray76 and by Langmuir–Blodgett tech-
niques,77,78 producing a variety of characteristics in terms of
sensitivity, selectivity and response time. However, it is widely
accepted that Nafion does not adhere to metal surfaces well and
that the process of thermal annealing of a cast Nafion
membrane produces a more adherent film.14,79–84 More impor-
tantly, it has been shown that thermal annealing also produces
a more selective membrane.14,85 However, the scientific literature
appears undecided on the most efficient method of Nafion
application regarding the number of applications, the tempera-
ture at which the application is applied, and the time for which
the application is allowed to dry before the addition of further
applications.4,59,61,63,74,86–94
We have recently addressed this issue by examining various
Nafion coating procedures on Pt in order to design a simple and
reproducible coating method to maximise permselective charac-
teristics.30 Application of Nafion (5% commercial solution)
using a thermally annealing procedure involving 5 pre-coats and
2 subsequent dip-bake layers resulted in elimination of interfer-
ent signals from AA (0–1000 mM), the principal endogenous
Fig. 2 (A) An example of the effect of bubbling N2 into an electro-
chemical cell containing 1 mM NO on the response of a Nafion-modified
Pt electrode at +900 mV vs. SCE. Increases in current represent injections
of 0.2, 0.4, 0.6, 0.8 and 1.0 mM NO. (B) Typical response to injection of
200 nM NO followed by the addition of 6 mM OxyHb.
Fig. 3 (A) Surface SEM of bare Pt disk electrode (10 mm dimensional
bar). (B) SEM of Pt-Nafion(5/2)-modified electrode (100 mm
dimensional bar).
This journal is ª The Royal Society of Chemistry 2009 Analyst, 2009, 134, 2012–2020 | 2015
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electroactive interferent present in the brain, UA (0–60 mM) and
DA (0–100 mM). Fig. 3 shows a typical SEM of this
Nafion(5/2)-modified electrode (220 magnification) compared
to bare Pt (540 magnification). We have now characterised this
sensor in terms of its sensitivity for NO (see Fig. 4) and its
permselective properties with respect to a wide range of poten-
tial endogenous interferents.95 The results of this characterisation
are presented in Table 1 and are compared to the average
responses observed at bare Pt. All interferents tested yielded
a significant decrease in response upon application of the
Nafion membrane with the majority producing no response in
calibrations performed over physiologically relevant concentra-
tion ranges, similar to that previously reported for AA.30 A
typical example for NO2
 is shown in Fig. 5. NO sensitivity on
the other hand, was increased (see Fig. 4; 1.67  0.08 nA mM1,
r2 ¼ 0.99, n ¼ 14) compared to bare Pt (1.08  0.20 nA mM1,
r2 ¼ 0.99, n ¼ 28, P ¼ 0.05) with a calculated limit of detection
(LOD) (3  SD of the background noise level) of 5 nM.
In addition, NO sensitivity was not affected by the presence
of physiological concentrations of AA (500 mM) and DA
(0.05 mM) in the electrochemical cell during calibrations: AA,
1.75  0.058 nA mM1, n ¼ 4, P ¼ 0.8552; DA,
1.79 0.37 nA mM1, n¼ 6, P¼ 0.8541. The hydrophobic nature
of NO permits it to pass freely across cell boundaries and
hydrophobic membranes. Nafion consists of a hydrophobic
fluorocarbon backbone and hydrophilic sulfonic groups. The
latter facilitate the interference rejection (i.e. anion repulsion)
while hydrophobic interactions, such as those previously
observed for other neutral molecules such as ferrocene96 and
methylmercury chloride,97 facilitate the permeation of the
neutral NO through the Nafion film.
Although the majority of NO sensors that have been modified
with a selective membrane (e.g. cellulose acetate) have shown
decreased sensitivity towards NO compared to the unmodified
electrode46,47,71,98 a similar increase in sensitivity to that reported
here has previously been observed by Diab and Schuhmann,66
also at a Nafion-modified electrode, although no reason was
given. A possible explanation is that adsorbed oxidation prod-
ucts decrease the sensitivity at electrodes not modified with
Nafion. Pariente et al.47 have reported that the mechanism of
NO oxidation at Pt surfaces involves the presence of adsorbed
intermediates according to the reaction:
NO(a) + H2O# HNO2(a) + H
+ + e
where (a) is used to represent an adsorbed species. However,
HNO2 may not be formed when NO is oxidised at Nafion
-
coated Pt because the negatively charged Nafion stabilises
the reaction product NO+, thus preventing a complicated
series of reactions that could lead to NO2
 and NO3

formation.14,26,47,62,99–102
Response time
Although Nafion can provide a sensor with selectivity against
electroactive interferents, it is commonly known that it reduces
the temporal response for target analytes.103 The relatively short
lifetime of NO in tissue (10–60 s) requires a sensor to respond
rapidly in order to continuously monitor changing concentra-
tions of NO in vivo.20 The response time achieved with the
Nafion(5/2)-modified Pt electrodes was 33.7  2.7 s (n ¼ 14, see
Fig. 4). This is slow compared to bare Pt where the response time
was 6.8  1.1 s (n ¼ 28, see Fig. 1).
In order to improve the response time, while at the same time
trying to retain the selectivity and sensitivity required to detect
the low concentrations of NO in brain ECF, we decided to
investigate the effects of reducing the thickness of the Nafion
coating in combination with incorporating poly(o-phenylenedi-
amine) (PPD). PPD has previously been used in sensor design as
an efficient permselective barrier against electroactive species
such as AA and DA without adversely affecting the response
time.14,71,104 It has also been used in the development of
a Nafion-modified carbon fibre-based NO sensor with a repor-
ted response time at 50% of 1 s.105 Reducing the number of
Nafion layers to 2 pre-coats/1 coat annealed at a temperature of
210 C, and adding an insulating outer layer of PPD resulted in
an improved response time of 19.0  3.4 s (n ¼ 8) compared
to the standard 5 pre-coats/2 coats sensor (33.7  2.7 s, n ¼ 14,
P ¼ 0.022). In addition, there was no significant effect on
NO sensitivity: Nafion(2/1)-PPD, 1.38  0.21 nA mM1 (n ¼ 8);
Nafion(5/2), 1.67  0.08 nA mM1 (n ¼ 14, P ¼ 0.1475).
There was also no effect on the interference rejection
characteristics with respect to the AA (Nafion(2/1)-PPD:
0.069 0.069 nA mM1, n¼ 3; Nafion(5/2):0.110 0.080 nA
mM1, n ¼ 3,‡ P ¼ 0.1661) and the NO2 response (Nafion
(2/1)-PPD: 0.29  0.17 nA mM1, n ¼ 3; Nafion(5/2):
0.028  0.016 nA mM1, n ¼ 5, P ¼ 0.1814).
Physiological conditions in vitro
Before performing experiments in vivo we tested the effects of two
important physiological conditions which could dramatically
affect the sensor response in vivo, namely temperature and
concentration of tissue O2. Calibrations for the Nafion
(5/2)
sensor carried out at 37 C (1.53  0.28 nA mM1, n ¼ 5)
displayed a similar sensitivity (P¼ 0.5002) to those carried out atFig. 4 Amperometric calibration plots for NO at bare Pt (dashed line)
and Nafion(5/2)-modified Pt (solid line) electrodes carried out in PBS,
pH 7.4, at +900 mV vs. SCE. Inset: Typical steady state currents obtained
for a 0–1.0 mM NO calibration using a Nafion(5/2)-modified Pt elec-
trode; arrows indicate injections of 0.2, 0.4, 0.6, 0.8 and 1 mM NO.
‡ A negative sensitivity is reported as there was no response to AA
additions and the background current drifted slightly below the
previously recorded baseline value over the time scale of the calibration.30
2016 | Analyst, 2009, 134, 2012–2020 This journal is ª The Royal Society of Chemistry 2009
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room temperature (25 C: 1.67  0.08 nA mM1, n ¼ 14). This is
in contrast to other reports where a doubling in NO sensitivity
was found on increasing the calibration temperature over the
same range.21 We did, though, observe an increase in background
current (25 C: 0.24  0.03 nA, n ¼ 14; 37 C: 3.10  0.38 nA,
n ¼ 5) which has also been observed by other research groups.106
However, the most encouraging characteristic displayed while
calibrating the sensors at 37 C was the significant decrease
(P ¼ 0.0029) in electrode response time to 14.00  2.52 s (n ¼ 5),
compared to 33.67 3.71 s (n¼ 14) at 25 C. Results presented in
the remaining sections of this manuscript are thus for the char-
acterisation of the Nafion(5/2) sensor only.
Since NO has a high tendency to react with molecular oxygen,
it was decided to characterise the NO response in the presence of
physiological concentrations of O2 (ca. 50 mM
86). Understanding
the effects of tissue O2 on the NO response is important if we
are to use in vitro calibration data to estimate in vivo concen-
trations. No significant difference (P ¼ 0.0882) was observed in
the NO sensitivity under N2-saturated (ca. 0 mM O2,
95
1.67  0.08 nA mM1, n ¼ 14) and 50 mM O2 conditions
(1.34  0.19 nA mM1, n ¼ 4) indicating that physiological
concentrations of O2 have negligible effect on the NO response
characteristics of the sensor.
Stability
We have previously reported on the shelf-life of the Nafion(5/2)
sensor where 14 days of storage at room temperature had no
significant effect on its AA interference characteristics.31
However, electrochemical detection of NO in vivo is not only
made difficult by the presence of electroactive interferents but
also by the presence of electrode poisons such as lipids and
proteins. While unmodified Pt electrodes have previously been
shown to be susceptible to electrode poisoning107 it has been
reported that Nafion enhances stability by protecting the elec-
trode surface against fouling.49,51,73 In fact, Mercado and Moussy
have shown that annealed Nafion is more biocompatible than
room temperature cast Nafion.108
In order to test the biocompatibility of our Nafion(5/2) sensor
we investigated the effect of its exposure to lipid (L-a-phospha-
tidylethanolamine, PEA) and protein (bovine serum albumin,
BSA) solutions109,110 on the NO sensitivity (1.67 0.08 nA mM1,
n ¼ 14). Storage for 24 h in 10% BSA resulted in a significant
decrease in sensitivity (1.19  0.24 nA mM1, n ¼ 3, r2 ¼ 0.998,
P ¼ 0.0346). However, on increasing the exposure time to 72 h
no further decrease was observed: 0.87  0.05 nA mM1, n ¼ 4,
r2 ¼ 0.971, P ¼ 0.2068. Exposure to 10% PEA resulted in
a similar decrease in sensitivity after 24 h (0.97  0.12 nA mM1,
n ¼ 4, r2 ¼ 0.992, P ¼ 0.0008), with an additional 48 h exposure
having no further effect (1.12  0.01 nA mM1, n ¼ 2, r2 ¼ 0.954,
P ¼ 0.4676). Pooling the data for 24 h and 72 h for each type of
treatment resulted in a 38.32% decrease in both cases. This is in
line with other reports where decreases of between 20 and 50%
have been observed following initial exposure of sensors to brain
tissue.111,112 These results highlight the need to adjust pre-
implantation calibration data to allow for lipid and protein
fouling or preferably to use post-in vivo data when estimating
concentration changes.
In vivo studies
While the in vitro characterisation results indicate that the
Nafion(5/2) sensor has the necessary properties in terms of
Table 1 Comparison of sensitivities of bare Pt and Nafion(5/2)-modified Pt electrodes to NO (CPA +900 mV vs. SCE) and potential endogenous
electroactive interferents at reported physiological concentrations.95 Number of electrodes in parenthesis
Analyte Bare Pt sensitivity Nafion-modified sensitivitya
NO 1.08  0.20/1.0 mM (28) 1.67  0.08 nA/1.0 mM (14)
AA 26.3  2.0 nA/500 mM (12) 0 nA/500 mM (3)
UA 1.53  0.05 nA/50 mM (4) 0 nA/50 mM (3)
5-HT 0 nA/0.01 mM (4) 0 nA/0.01 mM (4)
DOPAC 0.94  0.17 nA/20 mM (4) 0 nA/20 mM (4)
5-HIAA 0.99  0.10 nA/50 mM (4) 0 nA/50 mM (4)
DA 0.009  0.001 nA/0.05 mM (4) 0 nA/0.05 mM (4)
Glutathione 0.009  0.001 nA/50 mM (4) 0 nA/50 mM (4)
HVA 0.10  0.01 nA/10 mM (4) 0 nA/10 mM (4)
NO2
 0.56  0.11 nA/100 mM (3) 0.003  0.002 nA/100 mM (5)
H2O2 0.0043  0.0007 nA/0.1 mM (3) 0.0012  0.0002 nA/0.1 mM (3)
a 0 nA is reported in cases where there was no response to analyte addition. For example, 0.05 mM DA produced no change in the response of the
Nafion(5/2)-modified Pt electrodes: 0.043  0.009 nA, n ¼ 4 (background); 0.039  0.008 nA, n ¼ 4, P ¼ 0.8234 (0.05 mM).
Fig. 5 Amperometric calibration plots for NO2
 at bare Pt (solid line)
and Nafion(5/2)-modified Pt (dashed line) electrodes carried out in PBS,
pH 7.4, at +900 mV vs. SCE. Inset: Typical steady state currents obtained
for a 0–1000 mM NO2
 calibration using a Nafion(5/2)-modified Pt
electrode; arrows indicate injections of 200, 400, 600, 800 and 1000 mM
NO2
.
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selectivity, sensitivity and stability for in vivo neurochemical
monitoring of NO it is important to perform an in vivo charac-
terisation of the sensor to ensure the properties obtained in the
in vitro environment are maintained in the more complex
biological milieu. We thus performed some preliminary experi-
ments in freely-moving animals involving systemic administra-
tion of NO and the NO precursor L-arginine.
Systemic administration of stock NO resulted in a maximum
increase in signal of 35 5 pA (n¼ 5, P¼ 0.0020) above baseline
at 23  7 min post-injection, whereas L-arginine produced
a maximum signal increase of 71  14 pA (n ¼ 6, P ¼ 0.0043) at
22  6 min. Both signals remained elevated for ca. 10  2 min
and 25  15 min respectively before returning to baseline levels:
917  14 pA (pre-injection) vs. 913  71 pA (post-injection) at
64  15 min (P ¼ 0.1936). In vitro calibration data suggest that
these increases correspond to maximum concentration changes
of 22 nM and 45 nM respectively. Examples of both NO and
L-arginine injections are shown in Fig. 6 and Fig. 7, respectively,
and are compared with the effect of normal saline injection:
a small maximum increase in signal occurred after 3.0  0.7 min
before returning to baseline levels within 5.8 0.9 min (n¼ 4). A
similar short-lived injection stress-related response has previ-
ously been reported for other sensors and attributed to an
increase in cerebral blood flow.113 When compared with the
maximum increases associated with NO and L-arginine, signifi-
cant differences were found in both cases (NO, P ¼ 0.0043;
L-arginine, P ¼ 0.0091) indicating that the change in signal
associated with systemic administration of both compounds is
not due to the stress linked with injection.
These preliminary in vivo results suggest that the Nafion(5/2)
sensor responds to changes in NO in the striatum of freely-
moving rats. In the case of L-arginine the data provide the first
direct evidence of an NO increase associated with systemic
administration of the precursor, something which has been
indirectly assumed in previous reports where direct real-time NO
measurement was not possible.113,114
Conclusions
A novel Pt-based electrochemical sensor modified with cured
Nafion (5 pre-coats/2 dip-coats) and previously developed for
in situ real-time neurochemical monitoring30 has now been
characterised in vitro for the sensitive and selective detection of
NO in brain ECF at +0.9 V (vs. SCE). Results indicate enhanced
NO sensitivity compared to bare Pt, negligible interference from
potential endogenous interferents, and good operational char-
acteristics in terms of response time and stability, all suggesting
high potential for reliable in vivo recording of NO. Preliminary
in vivo experiments involving systemic administration of NO and
L-arginine in freely-moving rats support the latter. Future
experiments will involve a full in vivo characterisation of the
Nafion(5/2) sensor in terms of sensitivity, selectivity and
stability to ensure that the properties presented in this report are
maintained in the target biological environment of the brain.
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